| Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment D Gilden, RJ Cohrs, R Mahalingam, MA Nagel The Lancet Neurology 8 (8), 731-740, 2009 | 665 | 2009 |
| The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features MA Nagel, RJ Cohrs, R Mahalingam, MC Wellish, B Forghani, A Schiller, ... Neurology 70 (11), 853-860, 2008 | 584 | 2008 |
| Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency NH Mueller, DH Gilden, RJ Cohrs, R Mahalingam, MA Nagel Neurologic clinics 26 (3), 675-697, 2008 | 398 | 2008 |
| The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy MA Nagel, B Forghani, R Mahalingam, MC Wellish, RJ Cohrs, ... Neurology 68 (13), 1069-1073, 2007 | 270 | 2007 |
| Analysis of human alphaherpesvirus microRNA expression in latently infected human trigeminal ganglia JL Umbach, MA Nagel, RJ Cohrs, DH Gilden, BR Cullen Journal of virology 83 (20), 10677-10683, 2009 | 220 | 2009 |
| Neurological disease produced by varicella zoster virus reactivation without rash D Gilden, RJ Cohrs, R Mahalingam, MA Nagel Varicella-zoster virus, 243-253, 2010 | 218 | 2010 |
| Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension KC El Kasmi, SC Pugliese, SR Riddle, JM Poth, AL Anderson, MG Frid, ... The Journal of Immunology 193 (2), 597-609, 2014 | 214 | 2014 |
| Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis D Gilden, T White, N Khmeleva, A Heintzman, A Choe, PJ Boyer, C Grose, ... Neurology 84 (19), 1948-1955, 2015 | 213 | 2015 |
| Neurological complications of varicella zoster virus reactivation MA Nagel, D Gilden Current opinion in neurology 27 (3), 356-360, 2014 | 207 | 2014 |
| Varicella zoster virus vasculopathy: analysis of virus-infected arteries MA Nagel, I Traktinskiy, Y Azarkh, B Kleinschmidt-DeMasters, ... Neurology 77 (4), 364-370, 2011 | 193 | 2011 |
| The neurobiology of varicella zoster virus infection D Gilden, R Mahalingam, MA Nagel, S Pugazhenthi, RJ Cohrs Neuropathology and applied neurobiology 37 (5), 441-463, 2011 | 158 | 2011 |
| Update on varicella zoster virus vasculopathy MA Nagel, D Gilden Current infectious disease reports 16, 1-8, 2014 | 138 | 2014 |
| Analysis of varicella-zoster virus in temporal arteries biopsy positive and negative for giant cell arteritis MA Nagel, T White, N Khmeleva, A Rempel, PJ Boyer, JL Bennett, ... JAMA neurology 72 (11), 1281-1287, 2015 | 131 | 2015 |
| Virus vasculopathy and stroke: an under-recognized cause and treatment target MA Nagel, R Mahalingam, RJ Cohrs, D Gilden Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2010 | 131 | 2010 |
| Complications of varicella zoster virus reactivation MA Nagel, D Gilden Current treatment options in neurology 15, 439-453, 2013 | 125 | 2013 |
| Vigilin binding selectively inhibits cleavage of the vitellogenin mRNA 3′-untranslated region by the mRNA endonuclease polysomal ribonuclease 1 KS Cunningham, RE Dodson, MA Nagel, DJ Shapiro, DR Schoenberg Proceedings of the National Academy of Sciences 97 (23), 12498-12502, 2000 | 106 | 2000 |
| The variegate neurological manifestations of varicella zoster virus infection D Gilden, MA Nagel, RJ Cohrs, R Mahalingam Current neurology and neuroscience reports 13, 1-10, 2013 | 104 | 2013 |
| Varicella zoster virus vasculopathy MA Nagel, AN Bubak The Journal of infectious diseases 218 (suppl_2), S107-S112, 2018 | 96 | 2018 |
| Varicella-zoster virus vasculopathy: immune characteristics of virus-infected arteries MA Nagel, I Traktinskiy, KR Stenmark, MG Frid, A Choe, D Gilden Neurology 80 (1), 62-68, 2013 | 94 | 2013 |
| The protean neurologic manifestations of varicella-zoster virus infection MA Nagel, DH Gilden Cleveland Clinic journal of medicine 74 (7), 489, 2007 | 91 | 2007 |
